Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion, EMT, ROS production, and decreased CXCR4 and IL-6 receptor expression through MAOA/mTOR/HIF-1α signaling53. The gene discussed is MTOR; the disease is prostate carcinoma.